Hospital management company Universal Health Services (NYSE: UHS) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 9.6% year on year to $4.50 billion. Its non-GAAP profit of $5.65 per share was 3.5% above analysts’ consensus estimates.

Is now the time to buy Universal Health Services? Find out by accessing our full research report, it’s free.

Company Overview

With a network spanning 39 states and three countries, Universal Health Services (NYSE: UHS) operates acute care hospitals and behavioral health facilities across the United States, United Kingdom, and Puerto Rico.

Revenue Growth

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Over the last five years, Universal Health Services grew its sales at a decent 8.6% compounded annual growth rate. Its growth was slightly above the average healthcare company and shows its offerings resonate with customers.

Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Universal Health Services’s annualized revenue growth of 10.1% over the last two years is above its five-year trend, suggesting some bright spots.

Universal Health Services also reports same-store sales, which show how much revenue its established locations generate. Over the last two years, Universal Health Services’s same-store sales averaged 3.6% year-on-year growth. Because this number is lower than its revenue growth, we can see the opening of new locations is boosting the company’s top-line performance.

This quarter, Universal Health Services reported year-on-year revenue growth of 9.6%, and its $4.50 billion of revenue exceeded Wall Street’s estimates by 2.4%.

Looking ahead, sell-side analysts expect revenue to grow 5.4% over the next 12 months, a deceleration versus the last two years. We still think its growth trajectory is satisfactory given its scale and indicates the market sees success for its products and services.

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.

Adjusted Operating Margin

Universal Health Services was profitable over the last five years but held back by its large cost base. Its average adjusted operating margin of 9.9% was weak for a healthcare business.

On the plus side, Universal Health Services’s adjusted operating margin rose by 1.6 percentage points over the last five years, as its sales growth gave it operating leverage. This performance was mostly driven by its recent improvements as the company’s margin has increased by 2.9 percentage points on a two-year basis.

This quarter, Universal Health Services generated an adjusted operating margin profit margin of 11.7%, in line with the same quarter last year. This indicates the company’s overall cost structure has been relatively stable.

Earnings Per Share

Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions.

Universal Health Services’s EPS grew at 13.8% compounded annual growth rate over the last five years, higher than its 8.6% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded.

Diving into Universal Health Services’s quality of earnings can give us a better understanding of its performance. As we mentioned earlier, Universal Health Services’s adjusted operating margin was flat this quarter but expanded by 1.6 percentage points over the last five years. On top of that, its share count shrank by 28.1%. These are positive signs for shareholders because improving profitability and share buybacks turbocharge EPS growth relative to revenue growth.

In Q1, Universal Health Services reported adjusted EPS of $5.65, up from $4.84 in the same quarter last year. This print beat analysts’ estimates by 3.5%. Over the next 12 months, Wall Street expects Universal Health Services’s full-year EPS of $22.57 to grow 6.1%.

Key Takeaways from Universal Health Services’s Q1 Results

It was encouraging to see Universal Health Services beat analysts’ revenue expectations this quarter. We were also glad its EPS outperformed Wall Street’s estimates. Overall, we think this was a solid quarter with some key areas of upside. The stock traded up 1.4% to $184 immediately following the results.

Universal Health Services put up rock-solid earnings, but one quarter doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here (it’s free).